M.E.I. Schipper

Heidelberg University, University Medical Center Utrecht

Papers

4

Total Citations

370

H-Index

4

About

Dr. M.E.I. Schipper is a pioneering surgeon whose work has fundamentally advanced the field of minimally invasive esophageal surgery, particularly through the application of robotic technology. Her primary research areas focus on improving surgical outcomes for esophageal cancer patients by reducing the morbidity associated with traditional open procedures. Dr. Schipper’s most significant contribution is leading the landmark ROBOT trial (2012), a randomized controlled trial that compared robot-assisted minimally invasive thoraco-laparoscopic esophagectomy to open transthoracic esophagectomy. This highly influential study, cited over 179 times, provided critical evidence supporting the safety and efficacy of the robotic approach. Her earlier work (2009) on robot-assisted thoracoscopic esophagectomy, with 149 citations, established the short- and mid-term feasibility of the technique. Notably, she also performed the first reported robot-assisted thoracoscopic esophagectomy for a giant upper esophageal leiomyoma (2007), showcasing her innovative application of robotics to complex cases. Through these achievements, Dr. Schipper has helped shape the modern surgical landscape, offering patients a less invasive path to recovery.

Research Focus

Key Achievements

4
H-Index
4
Papers
370
Total Citations
93
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)
179 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Heidelberg University, University Medical Center Utrecht

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago